{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:31:49Z","timestamp":1791311509796,"version":"4.3.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jbspin.2010.06.004","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T08:44:21Z","timestamp":1285058661000},"page":"118-123","source":"Crossref","is-referenced-by-count":47,"title":["Blood vessels, a potential therapeutic target in rheumatoid arthritis?"],"prefix":"10.1016","volume":"78","author":[{"given":"Luca","family":"Semerano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Assier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christophe","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.06.004_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2007.09.006","article-title":"Endothelial progenitor cells and rheumatic disorders","volume":"75","author":"Avouac","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00109-007-0258-2","article-title":"Pericytes: gatekeepers in tumour cell metastasis?","volume":"86","author":"Gerhardt","year":"2008","journal-title":"J Mol Med"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2613.2009.00640.x","article-title":"The vasculature in rheumatoid arthritis: cause or consequence?","volume":"90","author":"Paleolog","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s10456-007-9081-1","article-title":"Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience","author":"Khong","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncprheum0559","article-title":"Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis","volume":"3","author":"Lainer-Carr","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0035","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.0611022104","article-title":"VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases","volume":"104","author":"Rad","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0040","doi-asserted-by":"crossref","unstructured":"Tarallo V, Vesci L, Capasso O, et al. A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization. Cancer Res 2010;70:1804\u201313.","DOI":"10.1158\/0008-5472.CAN-09-2609"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","article-title":"Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders","volume":"979","author":"Luttun","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0055","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1523-1755.1999.00610.x","article-title":"Role of vascular endothelial growth factor in the regulation of angiogenesis","volume":"56","author":"Ferrara","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1541-7786.MCR-07-0072","article-title":"Angiopoietin: a TIE(d) balance in tumor angiogenesis","volume":"5","author":"Shim","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1525-0016(03)00034-0","article-title":"Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors","volume":"7","author":"Arsic","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0070","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.yexcr.2005.09.002","article-title":"Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling","volume":"312","author":"Eklund","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbspin.2009.05.011","article-title":"New insights in synovial angiogenesis","volume":"77","author":"Szekanecz","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","article-title":"Angiogenesis and chronic inflammation: cause or consequence?","volume":"10","author":"Costa","year":"2007","journal-title":"Angiogenesis"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jbspin.2010.06.004_bib0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/ard.61.suppl_2.ii96","article-title":"Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases","volume":"61","author":"Wilder","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jhsa.2007.09.002","article-title":"Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis","volume":"33","author":"Sivakumar","year":"2008","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0095","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7","article-title":"Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint","volume":"44","author":"Hollander","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0100","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/ar756","article-title":"Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis","volume":"5","author":"Giatromanolaki","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.27287","article-title":"Angiogenesis and blood vessel stability in inflammatory arthritis","volume":"62","author":"Kennedy","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0110","first-page":"202","article-title":"Relationship between angiogenesis and inflammation in experimental arthritis","volume":"17","author":"Clavel","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0115","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.4049\/jimmunol.164.11.5922","article-title":"Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis","volume":"164","author":"Lu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/bbrc.2001.4395","article-title":"Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice","volume":"281","author":"Sone","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0125","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.gt.3302104","article-title":"Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis","volume":"10","author":"Afuwape","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0130","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.171.9.4853","article-title":"Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K\/BxN model of rheumatoid arthritis","volume":"171","author":"De Bandt","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00011-003-1230-4","article-title":"Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787\/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis","volume":"53","author":"Grosios","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0140","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar2447","article-title":"Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis","volume":"10","author":"Jin","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0145","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/art.21016","article-title":"Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction","volume":"52","author":"Chen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","article-title":"2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF","volume":"3","author":"Mabjeesh","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/cimm.1994.1223","article-title":"Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol","volume":"157","author":"Oliver","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0160","doi-asserted-by":"crossref","unstructured":"Koh MY, Spivak-Kroizman TR, Powis G. HIF-1alpha and cancer therapy. Recent Results Cancer Res 2010;180:15\u201334.","DOI":"10.1007\/978-3-540-78281-0_3"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0165","first-page":"273","article-title":"A single infusion of infliximab increases the serum endostatin level in patients with rheumatoid arthritis","volume":"21","author":"Kucharz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2007.03.057","article-title":"Blockage of the formation of new blood vessels by recombinant human endostatin contributes to the regression of rat adjuvant arthritis","volume":"567","author":"Yue","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0175","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/art.10113","article-title":"Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis","volume":"46","author":"Kim","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0180","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar608","article-title":"The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis","volume":"5","author":"Sumariwalla","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/ard.2008.093153","article-title":"Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis","volume":"68","author":"Trocme","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0190","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00296-007-0317-6","article-title":"Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?","volume":"27","author":"Erdem","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0195","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0002-9440(10)63259-2","article-title":"Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"165","author":"Park","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/keh423","article-title":"Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study","volume":"44","author":"Bongartz","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0205","first-page":"372","article-title":"Angiocidal effect of cyclosporin A: a new therapeutic approach for pathogenic angiogenesis","volume":"24","author":"Wilasrusmee","year":"2005","journal-title":"Int Angiol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10585-005-5377-y","article-title":"Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma","volume":"22","author":"Tomoda","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0215","doi-asserted-by":"crossref","first-page":"R326","DOI":"10.1186\/ar1182","article-title":"Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study","volume":"6","author":"Goedkoop","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0220","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","article-title":"Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy","volume":"54","author":"Markham","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0225","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/039463200902200214","article-title":"Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation","volume":"22","author":"Campanati","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0230","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002620100181","article-title":"The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gamma","volume":"50","author":"Paradis","year":"2001","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0240","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.11143","article-title":"Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis","volume":"48","author":"Nakahara","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0245","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-09-0287","article-title":"Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma","volume":"15","author":"Shinriki","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0250","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clpt.2006.05.011","article-title":"Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis","volume":"80","author":"Cardillo","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0265","first-page":"373","article-title":"Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0270","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","article-title":"Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy","volume":"114","author":"Maki-Petaja","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0275","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/ken486","article-title":"Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage\/dysfunction","volume":"48","author":"Foster","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0280","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm948","article-title":"Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells","volume":"9","author":"Aicher","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0285","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/ard.2006.066605","article-title":"Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy","volume":"66","author":"Grisar","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0290","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.0000236064.19293.79","article-title":"Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population","volume":"37","author":"Fadini","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0295","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jbspin.2009.04.007","article-title":"Endothelial progenitor cells in arthritis-associated vasculogenesis and atherosclerosis","volume":"76","author":"Pakozdi","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.06.004_bib0300","doi-asserted-by":"crossref","unstructured":"van Zonneveld AJ, de Boer HC, van der Veer EP, et al. Inflammation, vascular injury and repair in rheumatoid arthritis. Ann Rheum Dis 2010;69(Suppl.\u00a01):57\u201360 [i].","DOI":"10.1136\/ard.2009.119495"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T23:49:59Z","timestamp":1559692199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1297319X10002113"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.06.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}